High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu heart program.

High density lipoprotein (HDL) cholesterol has been inversely associated with coronary heart disease. Associations with stroke are less clear, particularly among the elderly. In this study, the authors examined the relation between HDL cholesterol levels and the risk of stroke in elderly men. Levels of HDL cholesterol were measured in 2,444 Honolulu Heart Program men aged 71-93 years at the 1991-1993 examinations. The participants, who were free of prevalent stroke, coronary heart disease, and cancer at baseline, were followed to the end of 1998 for thromboembolic and hemorrhagic stroke. While HDL cholesterol was unrelated to hemorrhagic events, incidence of thromboembolic stroke declined consistently with increasing HDL cholesterol level (p = 0.003). There was a nearly threefold excess of thromboembolic stroke in men with low HDL cholesterol levels (<1.0 mmol/liter (<40 mg/dl)) compared with men with high levels (> or =1.6 mmol/liter (> or =60 mg/dl)) (10.6/1,000 person-years vs. 3.6/1,000 person-years; p = 0.001). Adjustment for other risk factors had little effect on these findings, although associations appeared strongest in elderly men with "desirable" total cholesterol levels, hypertension, or diabetes mellitus. These findings suggest that HDL cholesterol level is inversely related to the risk of thromboembolic stroke in elderly men. Whether HDL cholesterol alters the effect of other factors on stroke risk in elderly men warrants further study.

[1]  A. Hardy,et al.  Mortality , 1953, The Panama Railroad.

[2]  J. Michael Gaziano,et al.  Cholesterol and the Risk of Ischemic Stroke , 2003, Stroke.

[3]  R. Abbott,et al.  Age-related changes in risk factor effects on the incidence of thromboembolic and hemorrhagic stroke. , 2003, Journal of clinical epidemiology.

[4]  D. Tanné,et al.  Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry. , 2002, Archives of internal medicine.

[5]  P. Elwood,et al.  Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe , 2002, Journal of epidemiology and community health.

[6]  R. D'Agostino,et al.  Risk of Hospitalized Stroke in Men Enrolled in the Honolulu Heart Program and the Framingham Study: A Comparison of Incidence and Risk Factor Effects , 2002, Stroke.

[7]  K. Yano,et al.  Ankle-brachial blood pressure in elderly men and the risk of stroke: the Honolulu Heart Program. , 2001, Journal of clinical epidemiology.

[8]  L. Brass,et al.  Reduction in Stroke With Gemfibrozil in Men With Coronary Heart Disease and Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) , 2001, Circulation.

[9]  R. Sacco,et al.  High‐density lipoprotein cholesterol and ischemic stroke in the elderly: The Northern Manhattan Stroke Study , 2001, JAMA.

[10]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[11]  D. Sprecher Raising high-density lipoprotein cholesterol with niacin and fibrates: a comparative review. , 2000, The American journal of cardiology.

[12]  S. Ebrahim,et al.  HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. , 2000, Stroke.

[13]  D. Rader,et al.  Overexpression of Secretory Phospholipase A2 Causes Rapid Catabolism and Altered Tissue Uptake of High Density Lipoprotein Cholesteryl Ester and Apolipoprotein A-I* , 2000, The Journal of Biological Chemistry.

[14]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[15]  K. Yano,et al.  Screening for coronary heart disease in elderly men based on current and past cholesterol levels. , 1999, Journal of clinical epidemiology.

[16]  J. Qiao,et al.  Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[17]  K. Yano,et al.  Changes in total and high-density lipoprotein cholesterol over 10- and 20-year periods (the Honolulu Heart Program). , 1998, The American journal of cardiology.

[18]  Alan C. Wilson,et al.  Risk factors for stroke and type of stroke in persons with isolated systolic hypertension , 1998 .

[19]  Y. Friedlander,et al.  Risk factors for ischemic stroke: Dubbo Study of the elderly. , 1998, Stroke.

[20]  R. D'Agostino,et al.  Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. , 1997, The New England journal of medicine.

[21]  D. Tanné,et al.  High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. , 1997, Stroke.

[22]  L. Chambless,et al.  Association of transient ischemic attack/stroke symptoms assessed by standardized questionnaire and algorithm with cerebrovascular risk factors and carotid artery wall thickness. The ARIC Study, 1987-1989. , 1996, American journal of epidemiology.

[23]  A. von Eckardstein,et al.  High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. , 1996, Atherosclerosis.

[24]  J. Gamble,et al.  High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[25]  R. Glynn,et al.  HDL cholesterol predicts coronary heart disease mortality in older persons. , 1995, JAMA.

[26]  K. Anderson,et al.  Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. , 1994, Journal of gerontology.

[27]  A. Folsom,et al.  High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. , 1994, Circulation.

[28]  D. Reed,et al.  Trends in Stroke Incidence and Mortality in Hawaiian Japanese Men , 1994, Stroke.

[29]  C. Burchfiel,et al.  Physical activity in older middle-aged men and reduced risk of stroke: the Honolulu Heart Program. , 1994, American journal of epidemiology.

[30]  C. Abbott,et al.  Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. , 1993, Atherosclerosis.

[31]  W. L. Ooi,et al.  Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  Y. Friedlander,et al.  Dubbo Study of the elderly: hypertension and lipid levels. , 1992, Atherosclerosis.

[33]  W. Willett,et al.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.

[34]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[35]  A. Tall Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. , 1990, The Journal of clinical investigation.

[36]  J Pekkanen,et al.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.

[37]  D. Gordon,et al.  High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.

[38]  P. Wilson,et al.  High Density Lipoprotein Cholesterol, Total Cholesterol Screening, and Myocardial Infarction: The Framingham Study , 1988, Arteriosclerosis.

[39]  D. Reed,et al.  Coronary heart disease, hypertension and stroke among Japanese-American men in Hawaii: the Honolulu Heart Program. , 1985, Hawaii medical journal.

[40]  P. W. Lane,et al.  Analysis of covariance and standardization as instances of prediction. , 1982, Biometrics.

[41]  W. Kannel,et al.  Lipoproteins, cardiovascular disease, and death. The Framingham study. , 1981, Archives of internal medicine.

[42]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[43]  S. Syme,et al.  Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. , 1974, Journal of chronic diseases.

[44]  D. Cox Regression Models and Life-Tables , 1972 .